Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2020-01-31 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
200131 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details transactions where UCB SA disposed of its own shares ('aliéné des actions UCB hors bourse') following the exercise of options by personnel, specifically mentioning the dates, quantities, and prices of these transactions. This directly corresponds to the definition of a company reporting transactions involving its own shares, which maps to the 'Transaction in Own Shares' category. Code mapping: Transaction in Own Shares -> POS.
2020-01-31 French
200131- Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and it details transactions where UCB NV delivered shares to its personnel under various Long-Term Incentive (LTI) plans (Stock Option Plans). This activity directly relates to the company managing its own share capital through employee compensation schemes. This aligns precisely with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase or issuance activities, including those related to employee stock options. It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K). It is a specific corporate action disclosure, making POS the most accurate classification over the general Regulatory Filing (RNS).
2020-01-31 Dutch
20100127- Disposal of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document is explicitly titled "Disposal of own shares" and details transactions where UCB SA/NV disposed of its own shares OTC following employee stock option exercises under various Long Term Incentive (LTI) Plans. This activity directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). Therefore, the appropriate filing type is Transaction in Own Shares (POS). The document is a direct announcement of the transaction, not merely an announcement of a report, so RPA/RNS is not the primary classification.
2020-01-27 English
20200127 - Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Aliénation d'actions propres" (Alienation of own shares) and details transactions where UCB SA alienated (sold/transferred) its own shares following the exercise of options by personnel, linked to long-term variable remuneration plans. This activity directly corresponds to the company buying back or selling its own shares, which is defined under the 'Transaction in Own Shares' category. The code for this is POS. The document is a formal announcement dated January 27, 2020, providing specific transaction details, which confirms it is a primary filing event, not just an announcement of a report (RPA/RNS).
2020-01-27 French
20200127- Vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details transactions where UCB NV delivered its own shares to employees as part of long-term incentive plans (stock options). This directly relates to the company managing its own share capital through transactions. The filing category 'Transaction in Own Shares' (Code: POS) is the most appropriate fit for reporting share repurchases or issuances/deliveries related to employee plans. The document is a formal announcement dated January 27, 2020, providing specific transaction details, not just an announcement of a report.
2020-01-27 Dutch
200120 - Transparency notification UCB SA.pdf
Director's Dealing Classification · 1% confidence The document is a 'Transparency notification' from UCB SA/NV, dated January 20, 2020, detailing a change in shareholding that caused the holding to cross downwards the 3% threshold on January 17, 2020. This type of filing, which reports personal share transactions by executives or significant changes in major share ownership, aligns directly with the definition of 'Director's Dealing' (if executives are involved, which is common in these disclosures) or 'Major Shareholding Notification'. Since the core content is the notification of a change in voting rights crossing a specific legal threshold (3%), the most precise category among the options is 'Major Shareholding Notification' (MRQ). It is not an Earnings Release (ER), Annual Report (10-K), or a general Regulatory Filing (RNS), as MRQ is a specific fit for crossing major ownership thresholds.
2020-01-20 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.